|
|
Studies of Rare Cancers
|
ZIA CP010158-01135
|
$15,968
|
$3,992
|
A Brinton, Louise
|
DCEG (NCI)
|
|
|
SPORE in Pancreatic Cancer
|
3P20CA101936-05S1
|
$521,256
|
$521,256
|
ABBRUZZESE, JAMES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185-10318
|
$182,222
|
$182,222
|
Abnet
|
DCEG (NCI)
|
|
|
The Golestan Cohort Study
|
ZIA CP000185-10361
|
$12,629
|
$12,629
|
Abnet
|
DCEG (NCI)
|
|
|
Risk factors for site-specific metastasis in esophageal cancer
|
5K07CA132892-02
|
$135,351
|
$135,351
|
Abrams, Julian
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Role of TLR4 in colitis-associated neoplasia
|
1R01CA137869-01A2
|
$316,155
|
$316,155
|
Abreu, Maria
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Regulation of Oncogene-Induced Senescence by Wnt-Signaling
|
7R01CA129334-02
|
$201,690
|
$70,592
|
ADAMS, PETER
|
UNIVERSITY OF GLASGOW
|
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-09
|
$1,475,007
|
$442,502
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-05
|
$288,389
|
$288,389
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Barriers to CRC in patients with mental illness.
|
1R03CA137825-01A1
|
$81,655
|
$81,655
|
AGGARWAL, ARPITA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-05
|
$239,551
|
$239,551
|
Ahmed, Yasmath
|
DARTMOUTH COLLEGE
|
|
|
Epigenetic markers involved in colorectal cancer recurrence and metastases
|
5K23CA127141-02
|
$140,940
|
$140,940
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$30,959
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Molecular Biomarkers as Classifiers to Individualize Therapy of Esophagus Cancer
|
1R21CA129906-01A2
|
$183,352
|
$183,352
|
Ajani, Jaffer
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Molecular Markers of Response to Chemoradiation in Localized Esophageal Cancer
|
5R21CA127672-02
|
$138,600
|
$138,600
|
Ajani, Jaffer
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$40,209
|
Albanes
|
DCEG (NCI)
|
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-10
|
|
$0
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-10
|
$511,052
|
$51,105
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Amplicons in Oral Dysplasia
|
5R01CA131286-02
|
$270,000
|
$270,000
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-05S1
|
$83,530
|
$20,883
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-05
|
$184,349
|
$46,087
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
1R01CA139599-01
|
$474,076
|
$237,038
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Neighborhood Characteristics Related to Cancer Risk Factors and Outcomes
|
5R21CA127777-02
|
$201,696
|
$66,560
|
ALLISON, MATTHEW
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
1R01CA118005-01A2
|
$340,386
|
$57,866
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-10
|
$288,775
|
$72,194
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
|
1R21CA129302-01A2
|
$191,676
|
$191,676
|
Altomare, Deborah
|
FOX CHASE CANCER CENTER
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$182,024
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
RNA Binding Proteins in Cancer
|
1R01CA135559-01A1
|
$303,988
|
$303,988
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
Dietary Prevention of Cancer
|
2R01CA109269-06A1
|
$283,480
|
$283,480
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
Dietary Prevention of Cancer
|
3R01CA109269-06A1S1
|
$58,803
|
$58,803
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-095
|
$1,562,516
|
$390,629
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
|
Extension of Radiotherapy Research
|
3P01CA006294-44S1
|
$300,000
|
$45,000
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Mouse Models of Sporadic Colorectal Cancer
|
5K01CA128891-02
|
$105,494
|
$105,494
|
Angus-Hill, Melinda
|
UNIVERSITY OF UTAH
|
|
|
Nicotine in Pancreatic Cancer: Molecular Mechanisms
|
5R21CA133753-02
|
$173,813
|
$173,813
|
ARAFAT, HWYDA
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Telomere Shortening and Stem Cell Maintenance
|
5K08CA118416-04
|
$140,010
|
$46,203
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Structural Basis of Multidrug resistance in Cancer
|
5K01CA113486-05
|
$155,422
|
$38,856
|
ASOJO, OLUWATOYIN
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-23
|
$2,304,698
|
$345,705
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$17,013
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
MODULATION OF INTESTINAL HOMEOSTASIS AND CANCER
|
1R01CA135561-01A1
|
$322,203
|
$322,203
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
|
Nutritional mechanisms and intestinal tumorigenesis
|
5R01CA114265-05
|
$250,767
|
$250,767
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$54,258
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$217,176
|
$195,458
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$542,939
|
$488,645
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$108,588
|
$86,870
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
|
ZIA BC 011005
|
$217,176
|
$86,870
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
Pancreatic Cancer Therapy with GRP Receptor-Targeted Imageable Diphenyl difluorok
|
1R03CA143614-01
|
$73,250
|
$73,250
|
AWASTHI, VIBHUDUTTA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
TGF-Beta signaling and microRNA processing: Implications for invasion and metasta
|
1F31CA142238-01
|
$33,528
|
$33,528
|
Azevedo, Ana Clara
|
OHIO STATE UNIVERSITY
|
|
|
Oncologist Communication Skills Intervention Assessment
|
5R21CA122303-02
|
$168,803
|
$168,803
|
BACK, ANTHONY
|
UNIVERSITY OF WASHINGTON
|
|
|
Spectroscopy of blood supply changes in early precancer
|
2R01CA109861-04A1
|
$248,443
|
$248,443
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
|
Spectroscopic Markers to Risk-Stratify Colonic Neoplasia
|
5R01CA112315-05
|
$170,197
|
$170,197
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Total relevant funding to Digestive Diseases for this search: $450,822,745
|
